Wellgistics Health Announces 1-for-50 Reverse Stock Split to Regain Nasdaq Compliance
Key Highlights
- Reverse Stock Split: Wellgistics Health, Inc. (NASDAQ: WGRX) has announced that its board of directors approved a 1-for-50 reverse stock split of its common stock, following majority shareholder approval on April 2, 2026.
- Effective Date: The reverse split will take legal effect at 12:01 a.m. Eastern Time on May 26, 2026.
- Trading and CUSIP: Post-split, the common stock will trade under a new CUSIP number.
- Purpose: The move is specifically intended to increase the per-share trading price, enabling the company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
Details of the Reverse Stock Split
- Every 50 shares of Wellgistics Health’s current common stock will automatically convert into one share of common stock.
- No fractional shares will be issued — any fractional shares resulting from the split will be rounded up to the nearest whole share.
- This action will reduce the number of outstanding shares from approximately 125,671,250 to about 2,513,425.
- Important for Shareholders: The total number of authorized shares will not be affected. Proportional adjustments will be made to the exercise and conversion prices of outstanding stock options, warrants, convertible securities, and to shares issued or issuable under stock incentive plans.
Shareholder Actions and Logistics
- Shareholders holding shares electronically (book-entry) do not need to take any action to receive post-split shares.
- Those holding shares via a bank, broker, or other nominee will have their positions automatically adjusted, subject to their brokers’ processes.
- No action is required from shareholders in connection with the reverse split.
Strategic Implications and Price Sensitivity
- Nasdaq Compliance: The reverse split is a critical move to ensure continued listing on the Nasdaq Capital Market, which requires the company’s shares to maintain a minimum bid price. Failure to comply could lead to delisting, which would significantly impact share liquidity and value.
- Share Value Impact: While the split itself does not change the total market capitalization, it will increase the per-share price, potentially attracting new investors and institutional interest. However, reverse splits can sometimes be perceived negatively by the market as a sign of financial distress.
- Fractional Shares: Rounding up of fractional shares may slightly increase the outstanding share count, but this effect is minimal.
- Stock Options and Warrants: All outstanding derivative securities will be adjusted proportionally, ensuring no dilution or windfall effects occur from the split itself.
Company Profile
Wellgistics Health, Inc. is a health information technology leader integrating proprietary pharmacy dispensing optimization AI (EinsteinRx™) with its blockchain-enabled smart contracts platform (PharmacyChain™). The platform connects over 6,500 pharmacies and 200+ manufacturers, providing services such as wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services including eligibility verification, onboarding, adherence support, prior authorization, and cash-pay fulfillment. These features are designed to improve patient access and transparency throughout the prescription ecosystem.
Forward-Looking Statements and Risks
This announcement contains forward-looking statements including, but not limited to, the effect of the reverse split on Nasdaq compliance, future business plans, and integration of new technologies. Risks include failure to complete proposed transactions, regulatory or board approvals, integration issues, and changes in reimbursement policy. Actual results may differ due to these and other factors beyond the company’s control.
Contact Information
Media: [email protected]
Investor Relations: [email protected]
Disclaimer
The information provided in this article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with a financial advisor before making investment decisions. The article may contain forward-looking statements subject to risks and uncertainties which could cause actual results to differ materially.
